Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wings apart-like protein homolog (WAPL) is a highly conserved eukaryotic protein that regulates chromosome architecture by controlling the dynamic association of the cohesin complex with chromatin through the cell cycle[1][2][3]. WAPL forms complexes with Pds5 to mediate the release of cohesin rings from chromatin, enabling chromosome segregation during mitosis and contributing to higher-order chromatin organization[1][2][3][5]. The protein features a flexible N-terminal domain and a conserved C-terminal domain composed of HEAT repeats, and it binds cohesin using specific recognition motifs[1][3][4]. Disruption of WAPL activity leads to chromosome segregation errors, highlighting its importance in genomic stability; however, WAPL itself is not a direct therapeutic target, and no drugs selectively modulate its activity as of current knowledge[2][5]. Key insights: - WAPL acts as a critical negative regulator of cohesin, controlling the timing of sister chromatid separation by releasing cohesin from chromosomes prior to anaphase[1][2][5]. - Mutations or experimental depletion of WAPL cause defects in chromosome segregation and lead to genomic instability[2][5]. - While WAPL is crucial for cell division fidelity, its direct pharmacological targeting is not established; rather, research focuses on cohesin pathway modulation for cancer and other disease states[2][4].
Not applicable (no drugs currently target WAPL directly; mechanistically, WAPL triggers opening of cohesin ring and release from DNA by interacting with specific cohesin subunits)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wings apart-like protein homolog (WAPL).